The race to produce a coronavirus vaccine accelerated on Monday when the German group BioNTech announced a $135m partnership with Fosun Pharma of China to develop a Covid-19 vaccine, which it said could begin clinical testing in late April.
研制新型冠状病毒疫苗的竞赛周一提速。德国生物技术集团BioNTech宣布与manbetx3.0 复星医药(Fosun Pharma)达成一项涉资1.35亿美元的合作，以开发COVID-19疫苗。该公司表示，这种疫苗有望于4月下旬开始临床试验。
您已阅读8%（352字），剩余92%（3968字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。